State of New Jersey Common Pension Fund D
LGND icon

State of New Jersey Common Pension Fund D’s Ligand Pharmaceuticals LGND Stock Holding History

State of New Jersey Common Pension Fund D’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.99M Sell
6,287
-439
-7% -$103K 0.01% 1060
2026
Q1 		$1.34M Buy
6,726
+37
+0.6% +$7.32K 0.01% 1383
2025
Q4 		$1.26M Sell
6,689
-6,832
-51% -$1.31M ﹤0.01% 1386
2025
Q3 		$2.4M Buy
+13,521
New +$2.01M 0.01% 929
2025
Q1 		– Sell
-18,776
Closed -$2.01M – 1541
2024
Q4 		$2.01M Buy
+18,776
New +$2.12M 0.01% 1228
2022
Q4 		– Sell
-37,408
Closed -$2.01M – 1713
2022
Q3 		$2.01M Buy
+37,408
New +$2.2M 0.01% 1368
2022
Q1 		– Sell
-27,806
Closed -$2.68M – 1747
2021
Q4 		$2.68M Sell
27,806
-13,438
-33% -$1.24M 0.01% 1451
2021
Q3 		$3.58M Buy
41,244
+8,718
+27% +$674K 0.01% 913
2021
Q2 		$2.66M Buy
32,526
+14,257
+78% +$1.19M 0.01% 1239
2021
Q1 		$1.74M Sell
18,269
-18,603
-50% -$1.76M 0.01% 1613
2020
Q4 		$2.29M Buy
36,872
+1,906
+5% +$109K 0.01% 1425
2020
Q3 		$2.08M Buy
34,966
+4,350
+14% +$297K 0.01% 1325
2020
Q2 		$2.14M Sell
30,616
-1,925
-6% -$122K 0.01% 1299
2020
Q1 		$1.48M Hold
32,541
– – 0.01% 1252
2019
Q4 		$2.12M Hold
32,541
– – 0.01% 1466
2019
Q3 		$2.02M Sell
32,541
-336,149
-91% -$21.1M 0.01% 1391
2019
Q2 		$26.3M Buy
368,690
+32,060
+10% +$2.36M 0.1% 235
2019
Q1 		$26.4M Buy
336,630
+160,300
+91% +$12.1M 0.1% 228
2018
Q4 		$14.9M Buy
176,330
+64,120
+57% +$6.84M 0.06% 312
2018
Q3 		$19.2M Sell
112,210
-48,090
-30% -$7.25M 0.07% 299
2018
Q2 		$20.7M Sell
160,300
-64,120
-29% -$7.15M 0.08% 291
2018
Q1 		$23.1M Hold
224,420
– – 0.09% 250
2017
Q4 		$19.2M Buy
224,420
+32,060
+17% +$2.78M 0.07% 287
2017
Q3 		$16.3M Sell
192,360
-48,090
-20% -$3.81M 0.07% 312
2017
Q2 		$18.2M Sell
240,450
-112,210
-32% -$7.85M 0.07% 288
2017
Q1 		$23.3M Sell
352,660
-64,120
-15% -$4.22M 0.1% 230
2016
Q4 		$26.4M Sell
416,780
-64,120
-13% -$4.05M 0.11% 208
2016
Q3 		$30.6M Buy
480,900
+240,450
+100% +$17.7M 0.13% 186
2016
Q2 		$17.9M Buy
+240,450
New +$17.8M 0.08% 266

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

State of New Jersey Common Pension Fund D's LGND Position: Q2 2026 in Review

State of New Jersey Common Pension Fund D reduced its Ligand Pharmaceuticals (LGND) stake by 6.5% in Q2 2026, selling an estimated $103K and leaving 6,287 shares worth $1.99M. The position accounts for 0.01% of the portfolio, ranked #1060.

State of New Jersey Common Pension Fund D first reported a position in LGND in Q2 2016 and has held it in 29 quarters since. The position peaked at $30.6M in Q3 2016. 192 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • State of New Jersey Common Pension Fund D held 6,287 shares of Ligand Pharmaceuticals worth $1.99M as of Q2 2026.
  • State of New Jersey Common Pension Fund D sold 439 Ligand Pharmaceuticals shares in Q2 2026, an estimated $103K.
  • Ligand Pharmaceuticals made up 0.01% of State of New Jersey Common Pension Fund D's portfolio in Q2 2026, its #1060 holding.
  • State of New Jersey Common Pension Fund D first reported a position in Ligand Pharmaceuticals in Q2 2016 and has held it in 29 quarters since.
  • State of New Jersey Common Pension Fund D's Ligand Pharmaceuticals position peaked at $30.6M in Q3 2016.
  • 192 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q2 2026, filed 4 Aug 2026.